AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
RISPERIDONE 2 Mg ;
9 registrations across 1 African market— 9 active
Markets with RISPERIDONE 2 Mg ;
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| Claviperdone 2 mg orally disintegrating Tablets | 🇪🇬Egypt | CLAVITA PHARMA | active | — |
| Risperidone 2 mg Film Coated Tablets | 🇪🇬Egypt | pharaonia pharmaceuticals (pharo pharma) | active | — |
| Apexidone 2mg Film Coated Tablets | 🇪🇬Egypt | Apex pharma | active | — |
| Schizodal 2 mg Film Coated Tablets | 🇪🇬Egypt | El OBOUR MODERN PHARMACEUTICAL INDUSTRIES-EGYPT | active | — |
| Zesperone 2 mg Film Coated Tablets | 🇪🇬Egypt | Sun pharma Egypt limited | active | — |
| Claviperdone 2 mg orally disintegrating Tablets | 🇪🇬Egypt | CLAVITA PHARMA | active | — |
| Risperidone 2 mg Film Coated Tablets | 🇪🇬Egypt | pharaonia pharmaceuticals (pharo pharma) | active | — |
| Apexidone 2mg Film Coated Tablets | 🇪🇬Egypt | Apex pharma | active | — |
| Zesperone 2 mg Film Coated Tablets | 🇪🇬Egypt | Sun pharma Egypt limited | active | — |
RISPERIDONE 2 Mg ; in Africa — Regulatory Overview
RISPERIDONE 2 Mg ; is registered across 1 African markets with 9 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Egypt. AfricaRegulatory refreshes this data daily from official government sources.
Of the 9 registrations, 9 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.